+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CytoDyn Inc - logo

CytoDyn is a biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of Human Immunodeficiency Virus (HIV) infection. The company has one of the leading monoclonal antibodies under development for HIV infection, PRO 140, which has finished Phase 2 clinical trials with demonstrated antiviral activity in man. The company is based in Vancouver, Washington.

Trogarzo (ibalizumab; Theratechnologies/TaiMed Biologics) Drug Overview 2019 - Product Thumbnail Image

Trogarzo (ibalizumab; Theratechnologies/TaiMed Biologics) Drug Overview 2019

  • Report
  • July 2019
  • 13 pages
Human Immunodeficiency Virus (HIV 1) Infection - Pipeline Insight, 2021 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV 1) Infection - Pipeline Insight, 2021

  • Drug Pipelines
  • February 2021
  • 60 pages
From
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2020 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 1285 pages
From
Human Immunodeficiency Virus (HIV) Therapeutics - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Therapeutics - Global Drug Forecast and Market Analysis to 2029

  • Report
  • February 2021
  • 254 pages
From
Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030 - Product Thumbnail Image

Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030

  • Report
  • April 2020
  • 536 Pages
From
Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030 - Product Thumbnail Image

Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030

  • Report
  • June 2018
  • 350 Pages
From
Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2021 - Product Thumbnail Image

Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2021

  • Report
  • June 2021
  • 650 Pages
From
Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
From
C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2019 - Product Thumbnail Image

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2019

  • Drug Pipelines
  • April 2019
  • 85 pages
From
Myasthenia Gravis (Immunology) - Drugs in Development, 2021 - Product Thumbnail Image

Myasthenia Gravis (Immunology) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
From
COVID-19 Therapy and Vaccine Drug Pipeline and Clinical Trials Report - January 2021 update - Product Thumbnail Image

COVID-19 Therapy and Vaccine Drug Pipeline and Clinical Trials Report - January 2021 update

  • Report
  • January 2021
  • 2400 Pages
From
Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2020 - Product Thumbnail Image

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 770 pages
From
COVID-19 Therapy and Vaccine Drug Pipeline and Clinical Trials Report - September 2020 Update - Product Thumbnail Image

COVID-19 Therapy and Vaccine Drug Pipeline and Clinical Trials Report - September 2020 Update

  • Report
  • September 2020
  • 2300 Pages
From
Psoriasis - Pipeline Review, H2 2020 - Product Thumbnail Image

Psoriasis - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 956 pages
From
Liver Cancer Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Liver Cancer Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • January 2020
  • 2099 pages
From
Prefilled Syringes Market (5th Edition), 2020-2030 - Product Thumbnail Image

Prefilled Syringes Market (5th Edition), 2020-2030

  • Report
  • January 2020
  • 554 Pages
From
Human Immunodeficiency Virus (HIV): Competitive Landscape to 2026 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV): Competitive Landscape to 2026

  • Report
  • February 2018
  • 52 pages
From
Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020 - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 693 pages
From
Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2021 - Product Thumbnail Image

Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2021

  • Report
  • April 2021
  • 2600 Pages
From
Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030 - Product Thumbnail Image

Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030

  • Report
  • October 2019
  • 302 Pages
From
Loading Indicator
adroll